Cytochrome b5 is tail-anchored in the ER membrane and is composed of three functionally different portions; amino-terminal heme-containing catalytic, central hydrophobic mem brane-anchoring, and carboxy-terminal ER-targeting portions [Mitoma, J. and Ito, A. (1992) EMBO J. 11,[4197][4198][4199][4200][4201][4202][4203]. In situ topology of cytochrome b5 in the ER membrane was studied using immunofluorescence microscopy. Antibodies were raised against the hydro philic portion (anti-b5) and the carboxy-terminal seven amino acid residues (anti-peptide) of cytochrome b5 and used for detection of the cytochrome in COS cells which expressed the rat cytochrome. Anti-b5 antibody detected the cytochrome in a reticular staining pattern characteristic of the ER, even when the cell plasma membrane was permeabilized with Streptolysin O. The anti-peptide displayed a fluorescence signal only with Triton-per meabilized cells in which the antibody was able to penetrate into the ER lumen. In a double immuno-staining of the cell using the antipeptide antibody and the antibody against protein disulfide isomerase, both antibodies showed the same staining pattern in the presence of either Triton X-100 or Streptolysin O. The results indicate that the carboxy terminal hydrophilic stretch is exposed to the luminal side. Cytochrome b5 was tagged with c-myc peptide at the carboxy-terminal end and the topology of the c-myc peptide was analyzed by the same method. Anti c-myc monoclonal IgG detected the tagged cytochrome b5 only after Triton treatment of the fixed cells, suggesting that the addition of c-myc peptide to the carboxy-terminal end does not affect insertion or orientation of the cytochrome in the ER membrane.
There has been increasing interest in the mechanism of targeting and insertion of "tail-anchored" proteins which are characterized by an amino-terminal cytosolic domain and a short carboxy-terminal anchoring domain. Cyto chrome b5 is a typical ER protein of such a class. The cytochrome has 134 amino acid residues and the mild proteolysis of the protein showed that it is composed of two domains, amino-terminal hydrophilic and carboxy-termi nal hydrophobic ones (1) (2) (3) . The amino-terminal domain of about 100 amino acid residues is exposed to the cytoplasm, contains a protoheme, and participates in the electron transfer function, whereas the carboxy-terminal "tail," consisting of about 30 amino acids, has two distinct parts, a hydrophobic membrane-anchoring part (about 20 residues) and a terminal hydrophilic part (about 7 residues). The carboxy-terminal ten amino acid residues contain sufficient information for targeting the cytochrome to the ER membrane (4) . The protein is synthesized on free poly somes and is inserted into the ER membrane without the participation of the SRP/SRP receptor system (5) (6) (7) (8) . 1 To whom correspondence should be addressed. Tel: +81-92-642-2530, Fax: +81-92-642-2607, E-mail: a.itoscc@mbox.nc.kyushu-u. ac.jp Abbreviations: ER, endoplasmic reticulum; PDI, protein disulfide isomerase; DMEM, Dulbecco's modified Eagle's medium; SLO, Streptolysin O.
In order to elucidate the mechanism of targeting and insertion of cytochrome b5 into the ER membrane, informa tion on the topology of the cytochrome in the membrane is essential. However, contradictory data on the topology of the cytochrome in the ER membrane have been derived from proteolytic studies. Ozols (9) showed that the peptide consisting of the carboxyl-terminal 6 amino acids of cyto chrome b, was released from the intact microsomal vesicles by externally added trypsin, suggesting that the mem brane-anchoring domain of the cytochrome turns in the ER membrane, forming a hairpin-like loop. On the other hand, Vergeres et al. (10) reported that cytochrome b5 inserted in vitro into microsomal membranes was sensitive to carboxypeptidase Y treatment only in the presence of a detergent, Tergitol, suggesting that the transmembrane domain of the cytochrome incorporated in vitro spans the membrane with its carboxy-terminus located in the lumen of the ER.
In this study, instead of an in vitro system, we applied an immunocytochemical method to determine the in situ orientation of the carboxy-terminal end of the cytochrome in the ER membrane, and here we present evidence of its existence on the luminal side. Fig.2) , the antibodies against b5 and the peptide used in this experiment cannot cross-react with any component, even the resident cytochrome b5, of the COS cells. The results indicate that the carboxy-terminal hydrophilic stretch is exposed to the luminal side of the ER.
To check the methodological reliability of our analysis, we applied a double immunostaining method to detect protein disulfide isomerase (PDI), a luminal protein of the ER, as well as the carboxy-terminal peptide of cytochrome b5 in the same cell (Fig.3) . When the cells were treated with Triton X-100 and stained with anti-PDI antibody to detect PDI protein, a reticular pattern of fluorescence was observed in all the cells, though the cell in the center of the figure was more clearly detected because it was in focus (Fig.3B) . The same cell was co-stained with the anti-peptide antibody in exactly the same pattern (Fig.3A) , indicat ing the co-localization of both antigens. On the other hand, the SLO-treated cells were not stained with either of the antibodies (Fig.3, C and D) . Thus, the protein localized in the ER lumen could be detected by the specific antibodies only in the Triton X-100-treated cells, indicating the Topology of c-myc Peptide Attached to the Carboxy-Terminal End of Cytochrome b5-Attachment of a tag to proteins is a useful method to detect the protein or a portion of the protein. C-myc peptide is one of the most useful tags because a specific antibody against the peptide is commer cially available. To examine whether we could use cyto chrome b5 tagged with c-myc peptide at the carboxy-termi nal end to study the mechanism of membrane insertion of the cytochrome, we examined if the mutant cytochrome has the same orientation as the wild type cytochrome. The c-myc-tagged cytochrome b5 was expressed in COS cells as and the topology of the c-myc peptide was analyzed by immunofluorescence microscopy, using anti-c-myc peptide antibody, 9E10 (Fig.4) . When COS cells expressing the cytochrome b5 tagged with c-myc peptide were permeabil ized by Triton X-100, the reticular network staining pattern of the ER was observed after incubation with both anti-b5 and anti-c-myc antibody (Fig.4, A and B) , indicat ing the localization of the mutant protein in the ER. The targeting of the c-myc-tagged cytochrome b5 to the ER suggests either that the targeting signal of the cytochrome need not be localized at the carboxy-terminal end of the molecule (4), or that the c-myc peptide functioned as the targeting signal, because the signal for targeting does not reside in a specific amino acid sequence, but instead in a balance of polar amino acid residues (Mitoma et al., unpublished results), and the amino acid sequence of c-myc peptide is similar to that of the carboxy-terminal portion of the cytochrome (12). When only the plasma membrane was permeabilized with SLO, the anti-c-myc antibody was unable to detect the peptide conjugated to cytochrome b5 (Fig.4D) . Thus, the c-myc peptide at the carboxy-terminal end of cytochrome b5 is exposed to the luminal side of the ER vesicle.
The same disposition of the mutated cytochrome in the ER membrane as that of the wild type cytochrome b5 was confirmed by their sensitivity to sodium carbonate and trypsin treatments. Microsomal membranes obtained from the COS cells expressing the wild-type and mutated cyto chrome b5 were treated with sodium carbonate (0.1 M) or trypsin. Most cytochrome b5 protein was recovered in the membrane fraction after treatment with Na2CO3 (data not shown), indicating that the mutated protein is an integral membrane protein, like the wild-type one. After the trypsin treatment of the microsomal membranes, a trypsin resistant hydrophilic core was detected at the same position in SDS PAGE as that of "trypsin b5" from rat liver microsomes (Fig.5) . Thus, the addition of c-myc peptide to the carboxy-terminal end does not affect insertion or orientation of the cytochrome b5 in the ER membrane.
DISCUSSION
The present results clearly indicate that the membrane anchoring domain of cytochrome b5 spans the ER mem brane and its carboxy-terminal hydrophilic stretch is exposed to the luminal side. This is the first clear indication of the in situ topology of a tail-anchored protein in membranes. Since cytochrome b5 has a proline residue in the middle of the membrane-anchoring domain, two types of conformation are possible in the ER membrane: loop and transmembrane conformations. The former might be possible if the proline exists in the cis configuration, whereas if the proline takes the trans configuration, the membrane-anchoring domain could form a conventional a -helix and span the entire membrane. The present in situ results support the transmembrane conformation of the membrane-anchoring domain of cytochrome b5. The conclu sion is confirmed by the result showing that mutation of the proline to alanine has no effect on the enzyme activity or the sensitivity to trypsin treatment of cytochrome b5 in the ER membrane (17) . The existence of a proline residue in the transmembrane domain of cytochrome b5 seems not to be essential for formation of the topology of the cytochrome in the ER membrane.
Since in vitro studies have shown that the purified cytochrome b5 can be spontaneously incorporated into various membranes, including liposomal membranes (18) (19) (20) as well as the ER membranes (21-23), cytochrome bs had been considered as a typical protein targeted through the receptor-independent, hydrophobic-insertion pathway and thus able to insert into any available hydrophobic environment (24, 25) . However, we have shown that a hy drophilic sequence of about 10 amino acids at the carboxy terminal end of cytochrome b5 is the signal responsible for targeting of the cytochrome to the ER membranes (4) . Although the minimum requirements of the amino acids in the carboxy-terminal sequence for the ER-targeting signal still remain unknown, the cytochrome b5 molecule may be first targeted to the ER membrane by a specific interaction of its carboxy-terminal signal with a receptor-like pro tein(s) and then anchored into the membrane by its hy drophobic portion. Since the carboxy-terminal end of cyto chrome b5 has a guanidyl group and three carboxy groups within the last seven amino acids, there might be specific machinery for the translocation of the highly polar end of the cytochrome across the ER membrane. Microsomal aldehyde dehydrogenase, another tail-anchored protein of the ER with a highly polar carboxy-terminal end (26, 27) , might share the same machinery for the insertion into the ER membrane.
Insertion of the cytochrome to the ER membranes has been studied for years (5) (6) (7) (8) (21) (22) (23) , but none of these studies determined the topology of the in vitro-inserted cytochrome. Vergeres et al. (10) have recently shown that in vitro-inserted cytochrome b5 is sensitive to carboxypeptidase Y treatment only in the presence of Tergitol and that the solubilized cytochrome was cleaved at bot lysine(93), which is in the amino-terminal portion, and arginine(127), which is in the carboxy-terminal hydrophilic portion, while the membrane-bound cytochrome was cleaved only at lysine(93). Their results, taken together with the present results, demonstrate the correctdisposition of the cyto chrome inserted in vitro into membranes. Kutay et al. (28) have recently indicated the transmembrane insertion of the hydrophobic tail of synaptobrevin, a tail-anchored protein of synaptic-like vesicles, into the ER membrane, by ex amining the N-glycosylation of the protein with a glycosyl ation site introduced at the carboxy-terminal portion, and they suggested participation of protein(s) in the insertion. In addition to these methods, the immunochemical method using antibodies against the carboxy-terminal sequence and the tag peptide will be a useful and reliable tool to analyze the topology of in vitro-inserted proteins. 
